Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section - Trial NCT06376058
Access comprehensive clinical trial information for NCT06376058 through Pure Global AI's free database. This phase not specified trial is sponsored by Aretaieion University Hospital and is currently Recruiting. The study focuses on Cesarean Section,Local Anesthetic. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Aretaieion University Hospital
Timeline & Enrollment
N/A
Jan 10, 2024
Jan 10, 2026
Primary Outcome
Time from spinal anesthesia to T10 block (min),Time from spinal anesthesia to T4 block (min),Time of spinal anesthesia to Bromage =3,level of sensory block every 3 min,level of sensory block every 15 min,highest level of sensory block,time from spinal anesthesia to highest level of sensory block,duration of sensory block,pain at surgical incision,pain at neonatal delivery,pain at peritoneal manipulation,pain at Post Anesthesia Care Unit (PACU) admission,pain at Post Anesthesia Care Unit (PACU) discharge,need for rescue analgesia intraoperatively,Bromage scale every 3 min after spinal anesthesia,Bromage scale every 15 min,duration of motor block,duration of staying in PACU
Summary
This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of
 chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean
 sections
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06376058
Non-Device Trial